Conceição Adrianny Larissa Oliveira, Corrêa Natália de Castro, Ferreira Patrícia Rodrigues, Rêgo Adriana Sousa, Silva Fabricio Brito, Carvalho Sarah Tarcísia Rebelo Ferreira de, Dias Rosane da Silva, Paz Bruna Katarine Beserra, Rocha Viviane Chaves de Carvalho, Bassi-Dibai Daniela
Department of Physical Therapy, Universidade Ceuma, São Luís, MA, Brazil.
Postgraduate Program on Program Management and Healthcare Services, Universidade Ceuma, São Luís, MA, Brazil.
Sao Paulo Med J. 2020 Jun;138(3):244-252. doi: 10.1590/1516-3180.2019.0524.05032020. Epub 2020 Jun 15.
The Finnish Diabetes Risk Score (FINDRISC) is a questionnaire that was developed by Finnish researchers to track the risk of diabetes.
To translate, cross-culturally adapt and validate the FINDRISC for use in Brazilian Portuguese.
Questionnaire validity study conducted at a private university.
The Brazilian version of the FINDRISC was developed through the processes of translation, back-translation, committee review and pre-testing. Test-retest reliability was measured using the intraclass correlation coefficient (ICC), kappa coefficient, standard error of measurement (SEM) and minimum detectable change (MDC). Internal consistency was measured using Cronbach's alpha. For construct validity, the total score of the FINDRISC was correlated with the Diabetes Knowledge Scale (DKN-A) and Diabetes Mellitus Risk Questionnaire (QRDM). Ceiling and floor effects were also evaluated in the present study.
For construct validity and floor and ceiling effect measurements, a total sample of 107 participants was used. For reliability, a subsample of 51 participants out of the total sample was used. We identified adequate values for reliability (kappa ≥ 0.79 and ICC = 0.98) and internal consistency (Cronbach's alpha = 0.84). Regarding the error inherent in the FINDRISC, we found SEM = 8.02% and MDC = 22.44%. There were significant correlations between the FINDRISC and the QRDM (r = 0.686) and DKN-A (r = -0.216). No ceiling or floor effects were found.
The Brazilian version of the FINDRISC has adequate psychometric properties that are in accordance with the best international recommendations.
芬兰糖尿病风险评分（FINDRISC）是一份由芬兰研究人员编制的用于追踪糖尿病风险的问卷。
将FINDRISC翻译成巴西葡萄牙语，进行跨文化调适并验证其有效性。
在一所私立大学进行问卷效度研究。
通过翻译、回译、委员会审核和预测试等流程编制巴西版FINDRISC。采用组内相关系数（ICC）、kappa系数、测量标准误（SEM）和最小可检测变化（MDC）来测量重测信度。使用Cronbach's alpha系数测量内部一致性。为评估结构效度，将FINDRISC的总分与糖尿病知识量表（DKN-A）和糖尿病风险问卷（QRDM）进行相关性分析。本研究还评估了天花板效应和地板效应。
为评估结构效度以及天花板和地板效应，共纳入107名参与者作为总样本。为评估信度，从总样本中选取51名参与者作为子样本。我们确定了足够的信度值（kappa≥0.79且ICC = 0.98）和内部一致性（Cronbach's alpha = 0.84）。关于FINDRISC固有的误差，我们发现SEM = 8.02%且MDC = 22.44%。FINDRISC与QRDM（r = 0.686）和DKN-A（r = -0.216）之间存在显著相关性。未发现天花板效应或地板效应。
巴西版FINDRISC具有良好的心理测量学特性，符合国际最佳推荐标准。
